SHORT REPORTSPrevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
References (10)
- et al.
Nebulised colimycin for early Pseudomonas colonisation in cystic fibrosis
Lancet
(1985) Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987
Chest
(1988)Antibiotic treatment. Aerosol therapy
Chest
(1988)- et al.
Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
Acta Paediatr Scand
(1983)
There are more references available in the full text version of this article.
Cited by (444)
In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication
2023, Journal of Cystic FibrosisA critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials
2020, Journal of Cystic FibrosisCitation Excerpt :Table 1 describes the different definitions used for first lifetime or positive Pa culture after a stated time scale in studies aiming for Pa eradication. This includes first lifetime documented culture positive for Pa [17–20] or positive Pa culture following a negative Pa timescale for: 6 months [21–23], 1 year [24–29] and 2 years [30–32]. Other differences among the studies included the type/combination of samples collected sputum versus oropharyngeal (OP) swabs versus BAL [21,23,25,33–37] versus laryngeal suction [28,38].
Structural and functional characterization of TgpA, a critical protein for the viability of Pseudomonas aeruginosa
2019, Journal of Structural Biology51 - Pulmonary Disease in Cystic Fibrosis
2019, Kendig's Disorders of the Respiratory Tract in ChildrenCF Lung Disease - A German S3 Guideline: Pseudomonas aeruginosa
2024, Pneumologie
Copyright © 1991 Published by Elsevier Ltd.